<DOC>
	<DOCNO>NCT02941978</DOCNO>
	<brief_summary>The purpose study investigate impact motivational interviewing adherence patient AF oral anticoagulation ( OAC ) regimens . Half patient interview guide importance adherence OAC medication . Patients assigned intervention group contact 1 week , 2 month , 6 month 1 year discharge . Patients control group contact 1 year discharge .</brief_summary>
	<brief_title>Motivational Interviewing Support Oral AntiCoagulation Adherence Patients With Non-valvular Atrial Fibrillation ( MISOAC-AF )</brief_title>
	<detailed_description>Study Purpose : To investigate impact motivational interviewing adherence patient AF oral anticoagulation ( OAC ) regimens Trial Type : Randomised clinical study Clinical Design : Prospective , single center , randomize control study Primary Objective : The primary outcome overall adherence OAC regimen year hospitalization reason , report continuous binary outcome Secondary Objective : The secondary clinical outcome combine endpoint death , acute myocardial infarction , hemorrhagic/ischemic stroke major bleed 1 year Sample Size : 1000 subject Population : Subjects Non-valvular Atrial Fibrillation ( NVAF ) OAC therapy prescribe OAC therapy hospitalize reason . Intervention 1 . Motivational Interview - Baseline : At hospital discharge , patient assign intervention group contact person study physician ( MD ) give leaflet educate risk stroke importance adherence OAC medication . 2 . Motivational Interview - Follow-up : Patients assign intervention group contact via telephone pre-specified interview 1 week , 2 month , 6 month 1 year discharge . The three element medication adherence ( initiation , implementation , discontinuation ) evaluate . Based patient 's dose history , delegate study personnel ass whether intervention require provide specific support tailor needs patient Control Patients assign control group contact via telephone pre-specified interview 1 year discharge Clinical Duration : The total study duration expect 3 year</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Subject history paroxysmal , persistent permanent NVAF 2 . Subject currently OAC therapy prescribe OAC therapy hospital discharge ( vitamin K antagonists nonvitamin K antagonist ) 3 . Subject 18 year old 4 . Subject legally authorized representative willing capable providing informed consent , participate associate study activity 1 . Subject unable communicate via telephone study interview 2 . Subject medical disorder would interfere completion evaluation clinical study result</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>